Results 81 to 90 of about 25,234 (166)

Euglycemic diabetic ketoacidosis with gastrointestinal dysfunction following lung surgery in a patient on SGLT2 inhibitor: a case report. [PDF]

AME Case Rep
Liu Y, Wen J, Cai W, Jin J, Hu M, Han H, Qiu X, Xue Z.   +7 more
europepmc   +1 more source

Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection. [PDF]

Diabetologia
Jansz TT, Young KG, Hopkins R, McGovern AP, Shields BM, Hattersley AT, Jones AG, Pearson ER, Bingham C, Oram RA, Dennis JM, MASTERMIND Consortium.   +11 more
europepmc   +1 more source

Sex-consistent outcomes in SGLT2 inhibitor-treated acute myocardial infarction patients: a real-world study. [PDF]

Eur J Med Res
Guo C, Dou JH, Guo FS, Zhao S, Wu RY, Hu YW, Liu S, Wei J.   +7 more
europepmc   +1 more source

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

JAMA Netw Open
Chung MC, Yu TM, Wu LY, Wu MJ, Shieh JJ, Chung CJ.   +5 more
europepmc   +1 more source

Characteristics and Outcomes of IgA Nephropathy Patients With SGLT2 Inhibitor-Induced Polycythemia. [PDF]

Cureus
Furuto Y, Namikawa A, Sato D, Shibuya Y.
europepmc   +1 more source

Favorable outcomes of SGLT2 inhibitor use in pacemaker recipients: a population-based study. [PDF]

Cardiovasc Diabetol
Avidan Y, Danon A, Hadar D, Aker A, Yahav A, Caspi O, Kassem S.   +6 more
europepmc   +1 more source

Unmasking of SGLT2 inhibitor associated ketoacidosis after initiation of mechanical ventilation with consecutive cardiopulmonary resuscitation and extracorporeal life support: A case report. [PDF]

Eur J Anaesthesiol Intensive Care
Nienhaus J, M'Pembele R, Kindgen-Milles D, Dalyanoglu H, Roth S.   +4 more
europepmc   +1 more source

Clinical outcomes of SGLT2 inhibitor use in Thai patients with heart failure: a five-year retrospective cohort study. [PDF]

Int J Cardiol Heart Vasc
Chanchanayothin T, Klomwong C, Saisri T, Panudom S, Chaiyamahapurk S, Theerasuwipakorn N, Siranart N, Pajareya P, Songsirisuk N, Pravarnpat C, Pipatputthapong A, Jittham P, Kosum P.   +12 more
europepmc   +1 more source

SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series. [PDF]

Adv Hematol
Artz A, Nguyen T, Samoa R, Kim H, Tse W, Jin R, Goutnik S.   +6 more
europepmc   +1 more source

Emphysematous Cystitis in an Immunocompetent Patient on an SGLT2 Inhibitor. [PDF]

Cureus
Nguyen KN, Bista DR.
europepmc   +1 more source